Stereotactic Surgery Devices Market | Unlocking Potential in Minimally Invasive Brain Interventions

The Stereotactic Surgery Devices Market is expected to increase from US$ 26.34 billion in 2023 to US$ 39.36 billion by 2033.

Overall Stereotactic Surgery Devices Market

The primary factors driving demand for Stereotactic Surgery Devices are rising demand for minimally invasive operations, increasing cancer prevalence, and technological improvement in stereotactic surgery equipment.

With governments and various healthcare professionals focused on research and development and investments in the healthcare sector, the next developments might drive the expansion of the stereotactic surgery instruments industry. Furthermore, the increasing use of these devices in patients with arteriovenous malformations, epilepsy, and Parkinson's disease is likely to provide a substantial boost to the market in the future years. The rising prevalence of these medical disorders is also projected to accelerate the adoption of stereotactic surgery instruments.

One of the most effective cancer treatments is radiosurgery. Stereotactic radiosurgery allows for the precise treatment of malignancies with high-dose radiation. Technical improvements in stereotactic radiosurgery aid in boosting treatment precision. Moreover, stereotactic radiosurgery aids in concentrating radiation dose on tumor cell lining, reducing the influence of radiation on adjacent healthy tissues.

Stereotactic radiosurgery and accompanying equipment are incorporating a variety of technologies. Radiosurgery therapies based on Varian technology help physicians treat many forms of cancer. Varian Medical Systems provide the Edge radiosurgery system, which is based on Varian technology and includes other technological components. Clinics, for example, can employ this modern equipment to perform streamlined stereotactic radiosurgery with speed and precision.

Despite the numerous benefits of stereotactic surgery, the expensive cost of stereotactic instruments is projected to stymie market expansion. Stereotactic radiosurgery can be delivered using ordinary Linear Accelerators (LINACs) or systems such as Gamma Knife. Unfortunately, many nations lack the financing and money to maintain such expensive radiation systems, which may have a negative impact on market growth.

Key Points from the Stereotactic Surgery Devices Market

  • The market is expected to surpass US$ 39.36 billion by 2033.
  • Rising surgical procedures, growing cancer prevalence, and increased government awareness campaigns are key factors boosting market expansion.
  • Stereotactic Surgery Devices market is expected to hold a CAGR of 4.1% during the forecast period 2023 to 2033.
  • North America dominated the Stereotactic Surgery Devices market.

Download Sample Report for Key Insights into the Market: https://www.futuremarketinsights.com/reports/sample/rep-gb-16922

Major players in the market are:

  • Koninklijke Philips N.V.
  • Hitachi Medical Systems
  • Huiheng Group
  • Siemens Ag
  • Elekta AB
  • Varian Medical Systems
  • IBA
  • Accuray Incorporated

Comments

Post a Comment

Popular posts from this blog

Targeted Therapies for Sandhoff Disease | Assessing the Global Market Landscape

Image
The global Sandhoff Disease Therapeutics Market Size is expected to be worth US$ 10 million in 2023 and US$ 17.91 million by 2033, with a CAGR of 6% from 2023 to 2033. From 2018 to 2022, the Sandhoff Disease Treatments market increased at a 4% CAGR. According to the most recent studies, Sandhoff sickness is a rare disorder that affects 1 in 1,000,000 people. The rising demand for these medications is projected to spur the discovery of novel therapies, propelling the market forward in the coming years. Gene therapy is being investigated as a potential treatment for Sandhoff disease. The therapy restores the ability to break down GM2 ganglioside by delivering a functional copy of the missing enzyme into the patient's cells. This has the potential to reduce or stop disease progression while also improving patient quality of life. Key Takeaways from the Market Study   The Sandhoff Disease Therapeutics market increased at a 4% CAGR from 2018 to 2022. From 2023 to 2033, the global Sandh
Read more

A Safer Tomorrow | Emerging Trends in Hospital-Acquired Infection Control Market

Image
According to Future Market Insights' recently released Hospital-acquired Infection Control Market analysis report, global Hospital-acquired Infection Control sales in 2023 are expected to be US$ 6.5 billion. The market is expected to increase at a CAGR of 7% between 2023 and 2033, reaching $12.7 billion by 2033. Hospitals and intensive care units are predicted to create significant income in the market, with a CAGR of 7.6%. The occurrence of hospital-acquired infections, increasing proportion of surgical procedures, growing geriatric population and increasing prevalence of chronic diseases, technological advancements in sterilisation equipment, and growing awareness of environmental and personal hygiene are the key factors driving the Hospital-acquired infection control market. The increased use of e-beam sterilisation, as well as the reintroduction of ethylene oxide sterilisation, is predicted to increase demand for hospital-acquired infection management. The percentage of treatm
Read more

Transforming Trauma | Emerging Therapies and Interventions in Post-Traumatic Stress Disorder Treatment Market

Image
According to Future Market Insights, the Post-Traumatic Stress Disorder (PTSD) Treatment Market Sales would grow at a 5% CAGR between 2023 and 2033. By 2033, the global market for post-traumatic stress disorder (PTSD) therapy is expected to reach US$ 27.37 billion. The market's growth might be attributed to the increased prevalence of PTSD globally. According to the National Centre for PTSD, approximately 7-8% of the US population will develop PTSD at some point in their lives, with greater percentages among military veterans and persons who have experienced sexual assault or other types of trauma. The COVID-19 pandemic has also been highlighted as a possible cause of PTSD, with healthcare workers, first responders, and people immediately impacted by the virus being especially vulnerable. In addition, there is a growing emphasis on using digital therapies and other non-pharmacological techniques to treat PTSD. For example, virtual reality exposure treatment (VRET) has shown potent
Read more